rheumatology
Lupus

LLDAS validated as a treat-to-target endpoint for SLE

Achieving lupus low disease activity state (LLDAS) for any period of time is associated with significant protection against subsequent disease flares and organ damage accrual in people with SLE, according to an Australian-led study. Researchers say the study is the first to validate LLDAS as a treat-to-target endpoint, paving the way for LLDAS to become ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic